BDTX - CIK 0001701541
Black Diamond Therapeutics, Inc. (BDTX) reported revenue of $70.00M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $70.00M | - |
| FY 2024 | $0.00 | - |
| FY 2020 | $0.00 | - |
| FY 2019 | $0.00 | - |
| FY 2018 | $0.00 | - |
Black Diamond Therapeutics, Inc. (BDTX) reported revenue of $70.00M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2018 and fiscal 2025, Black Diamond Therapeutics, Inc.'s revenue grew from $0.00 to $70.00M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.